Anti-RGMa neutralizing antibody administration in ALS animals exerted a neuroprotective effect, resulting in a decrease in the SOD1-positive aggregates in motor neurons and a significant prolongation of survival in ALS animal models. The gene discussed is RGMA; the disease is amyotrophic lateral sclerosis.